Financing
AbbVie·Cash Flow Statement·9 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Proceeds from issuance of debt | — | — | $2B | $4B | — | — | — | $8B |
| Dividends paid | $2.8B | $2.8B | $2.8B | $2.9B | $2.9B | $2.9B | $2.9B | $3.1B |
| Repayments of other short-term debt | $3M | — | — | $0 | $0 | $2B | $791M | $2B |
| Repayments of Other Short-Term Debt | — | — | — | $0 | — | — | — | $2B |
| Repurchases of common stock | $9M | $17M | $358M | $961M | $12M | $4M | $3M | $1.5B |
| Net cash from financing activities | — | — | -$6.9B | -$1.3B | -$2.7B | -$4.6B | -$4.2B | $919M |
| Proceeds from (repayments of) short-term borrowings, net | $0 | $0 | $0 | $1.6B | — | — | — | -$499M |
| Other, net | $0 | $32M | $1M | $67M | — | $37M | — | $2M |
| Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security | $3.3B | $403M | $5.8B | $3B | $3.8B | $9M | $8M | $0 |